# Pilot Window of Opportunity Trial (POET)

> **NCT06129604** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Oklahoma** · enrollment: 10 (estimated)

## Conditions studied

- Colorectal Carcinoma (CRC)
- Endometrial Carcinoma (EC)

## Interventions

- **DRUG:** TPST-1495

## Key facts

- **NCT ID:** NCT06129604
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-03
- **Primary completion:** 2025-08-22
- **Final completion:** 2026-06-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06129604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06129604, "Pilot Window of Opportunity Trial (POET)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT06129604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*